Angion Biomedica Corp Stock, NASDAQ:ANGN
51 Charles Lindbergh Boulevard, Suite 1200, Uniondale, New York 11553
United States of America
Number of Employees: 53
Angion Biomedica Corp. operates as a biopharmaceutical company. It focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 06, 1998 and is headquartered in Uniondale, NY.